Drug solubilisation 2 Flashcards

1
Q

What are cyclodextrins?

A
  • They are cyclic oligasachharides that posses a rigid conical structure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cyclodextrins include a hydrophilic exterior and a hydrophobic inner core. TRUE OR FLASE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The hydroxyl groups on the exterior of the cyclodextrin structure forms H-bond with water and as result forms inclusion complexes. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hydrophobi drugs can be inserted in the hydrophobic inner core of the cyclodextrin to form hydrophobic-hydrophobic interactions. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism of encapsulation of cyclodextrins?

A
  • Inclusion complex is formed when water is removed and replaced by the lipophilic guest i.e hydrophobic drug
  • The central cavity plas host to hydrophobic drug forming non-covalent interactions with hydrophobic drug
  • This is an aletrnative ot micellear solubilisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

You can change the size of the core to accommodate the drug. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The solubility of the hydrophobic drug is enhanced by entrapment of inside the core. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what have cyclodextrins been prove to do?

A
  • Improve solubility
  • Enhave bioavailability
  • Protect drug while in vivo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The solubility of cyclodextrins is drug dependent on size and steric structure. TRUE OR FLASE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The drug must fit into the cyclodextrin core before ti becomes solubilised. TRUE OR FLASE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why are drug specific delivery systems problematic?

A
  • cost implications

- not in dynamic equilibrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are calixerenes?

A
  • They are a family of oligomers whihc have a 3 dimentional structures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when are calixerenes commonly used?

A
  • Commonly used as building blocks in supramolecular systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Calixarenes form 3D cupe like structures with well defined upper rim a upper and lower rims containing a central cavity in both the solid state and in soluiton. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Claixarenes posses metal biding site and hydrophobic core for host guest interactions with organic molecules. TRUE OR FALSE?

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do calixarenes enhance solubitlity of hydrophobic drugs?

A

Via hydrophobic interactions

17
Q

What affects the variation of calixarenes?

A
  • different solvents
  • Tempearture
  • functional groups
18
Q

Carixarenes are not rigid structures. TRUE OR FALSE?

19
Q

what advantages do calixarene have over cyclodextrins?

A
  • Can be chemically modfied easily with low toxic chemical reactions
  • It allows more targeted delivery as functional groups can be attached to the upper or lower rim
  • they have low production costs and low toxicity
20
Q

Just with cyclodextrins, drugs have to be sterically stable (physically stable) in order to bind into the steric pocket of the calixarene. TRUE OR FLASE?

21
Q

Calixarenes do not form generic drug solubilisers. TRUE OR FALSE?

22
Q

Propofol has low physiochemical properties which results in low aqueous solubility and hence hinders its use. TRUE OR FALSE?

23
Q

what is nanodrug formation?

A
  • When large insoluble drugs are milled down to nano sized particles
24
Q

The decrease in particle size leads to an increase in SA to volume ratio. TRUE OR FALSE?

25
what are the advantages of nanodrug formation?
- Solubility will be enhanced leading to use via I.V - Can administer lower doses which will have similar effects to large doses - Fewer side effects and more cost effectiveness
26
what are the advantages of nanodrug formation for oral drug delivery?
- For oral drugs, increased SA leads to increased dissolution rate and hence bioavailability which means that drug will reach its target (GI tract)
27
what are the advantages of nanodrug formation for pulmonary drug delivery?
- the drug can reach deep down lung tissue | - Once in target site it can easily cross the mucus memebranes
28
what are the disadvantages of nanonization (nanodrug formation)?
- Does not apply to all drug molecules - stability issues - Does not rival use of excipients
29
what are polymers?
- They are long chain molecules made up of repeating units with high molecular weights
30
Polymers are easily tailored for functionality using different chemistries. TRUE OR FALSE?
TRUE
31
What does a polymer drug conjugate consist of?
- Biocompatible polymer - Solubiliser - Drug - Targeting moiety
32
what does the water soluble backbone do in a polymer drug-conjugate?
- Increases aqueous solubility
33
what does drug conjugate do in a polymer drug conjugate?
- It allows for controlled delivery
34
what does taregting moeity do in polymer drug conjugate do?
- Enhances binding and cellular uptake
35
high molecular weigth increases accummulation via enhanced permeability and retention effect. TRUE OR FLASE?
TRUE
36
what are the advantages of polymer drug conjugates?
- Can increase circulation time - Can increase drug penetration - Can protect the drug - Also has benefits that other nano technologies have
37
what are the disadvantages of polymer drug conjugates?
- Need to use complex chemistry for linkers | - drug can become permanetly conjugated
38
what are the three types of nanottechnology used to solubilise drugs?
- Cyclodextrins - Calixeranes - Polymer drug conjugates - Nanonization